The store will not work correctly when cookies are disabled.
2-(9H-purin-6-ylthio)-1-(4-bromophenyl)ethanone
ID: ALA4781617
PubChem CID: 873941
Max Phase: Preclinical
Molecular Formula: C13H9BrN4OS
Molecular Weight: 349.21
Molecule Type: Unknown
Associated Items:
Names and Identifiers
Canonical SMILES: O=C(CSc1ncnc2[nH]cnc12)c1ccc(Br)cc1
Standard InChI: InChI=1S/C13H9BrN4OS/c14-9-3-1-8(2-4-9)10(19)5-20-13-11-12(16-6-15-11)17-7-18-13/h1-4,6-7H,5H2,(H,15,16,17,18)
Standard InChI Key: FJSCLTNZZSBMCX-UHFFFAOYSA-N
Molfile:
RDKit 2D
20 22 0 0 0 0 0 0 0 0999 V2000
5.3805 -4.8371 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.3793 -5.6566 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.0874 -6.0656 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.0856 -4.4282 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.7942 -4.8335 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.7990 -5.6521 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.5790 -5.9005 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
8.0564 -5.2354 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.5713 -4.5760 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.0832 -3.6110 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
5.3742 -3.2045 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.6677 -3.6153 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.9588 -3.2088 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.6702 -4.4324 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
3.9600 -2.3924 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.2519 -1.9860 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.5444 -2.3968 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.5495 -3.2182 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.2581 -3.6209 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.8349 -1.9912 0.0000 Br 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 6 2 0
5 4 2 0
4 1 1 0
5 6 1 0
6 7 1 0
7 8 1 0
8 9 2 0
9 5 1 0
4 10 1 0
10 11 1 0
11 12 1 0
12 13 1 0
12 14 2 0
13 15 2 0
15 16 1 0
16 17 2 0
17 18 1 0
18 19 2 0
19 13 1 0
17 20 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 349.21 | Molecular Weight (Monoisotopic): 347.9680 | AlogP: 3.09 | #Rotatable Bonds: 4 |
Polar Surface Area: 71.53 | Molecular Species: NEUTRAL | HBA: 5 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 5 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 9.91 | CX Basic pKa: 3.50 | CX LogP: 2.62 | CX LogD: 2.61 |
Aromatic Rings: 3 | Heavy Atoms: 20 | QED Weighted: 0.45 | Np Likeness Score: -1.39 |
References
1. Rojas-Prats E,Martinez-Gonzalez L,Gonzalo-Consuegra C,Liachko NF,Perez C,Ramírez D,Kraemer BC,Martin-Requero Á,Perez DI,Gil C,de Lago E,Martinez A. (2021) Targeting nuclear protein TDP-43 by cell division cycle kinase 7 inhibitors: A new therapeutic approach for amyotrophic lateral sclerosis., 210 [PMID:33139113] [10.1016/j.ejmech.2020.112968] |